Shri Ahimsa Naturals Limited
Book Built Issue IPO · NSE
- Price band
- ₹113 - ₹119
- Lot size
- 1,200 shares
- Issue amount
- ₹73.81 cr
- Total subscription
- 62.71×
- Opens
- 25 Mar 2025
- Closes
- 27 Mar 2025
- Allotment
- 28 Mar 2025
- Listing
- 2 Apr 2025
Offer at a glance
Issue overview
- Issue size
- 62,02,800 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,35,600
- Fresh issue
- ₹50.02 cr
- Offer for sale
- ₹23.79 cr
- Registrar
- Cameo Corporate Services Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,42,800
- Issue type
- Book Built Issue IPO
- Shares before issue
- 1,91,26,500
- Shares after issue
- 2,33,30,100
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,200 | ₹1,42,800 |
| HNI | 2 | 2,400 | ₹2,85,600 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | — | 35 |
| NIB | — | 5,465 |
| RETAIL | — | 60,723 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 13.92 | 295.58 |
| RETAIL | 24.78 | 866.98 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Sep-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 5.25 | 10.19 | 20.85 |
| ROE | 9.78 | 22.25 | 58.58 |
| ROCE | 12.59 | 25.69 | 72.46 |
| RONW | 9.78 | 22.25 | 58.58 |
| PRE IPO(PE) | 0 | 12.19 | 0 |
| POST IPO(PE) | 14.25 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Shri Ahimsa Naturals Limited has been around since 1990, specializing in extracting and producing Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine. They also trade in other herbal extracts. Their products are widely used in industries like food & beverages, nutraceuticals, cosmetics, and pharmaceuticals, thanks to their various health benefits. The company offers Natural Caffeine, sourced from coffee and tea seeds, which is commonly found in energy drinks, soft drinks, cosmetics, and medicines. They also produce Green Coffee Bean Extract, made from unroasted coffee seeds, known for its antioxidant properties and potential weight management benefits. Shri Ahimsa Naturals exports to several countries, including the USA, Germany, South Korea, the UK, and Thailand. For the period ending September 30, 2024, they reported export revenues of ₹3,530.91 lakhs. In previous years, exports reached ₹7,463.71 lakhs in Fiscal 2023, ₹5,633.50 lakhs in Fiscal 2022, and ₹9,988.01 lakhs in their highest fiscal year. Their manufacturing facility in Jaipur, Rajasthan, follows top global standards like ISO 9001:2015, ISO 22000:2018, ISO 45001:2018, ISO 14001:2015, HACCP, and GMP, ensuring high-quality production. As of March 2025, the company had around 80 employees.
Strengths
- Expert Leadership – Guided by seasoned professionals, fostering growth and innovation.
- Cutting-Edge Manufacturing & R&D – Modern facility in Jaipur, delivering high-quality products.
- Trusted Global Partnerships – Long-standing relationships across food & beverage, nutraceuticals, cosmetics, and pharmaceuticals.
Risk factors
- Project Execution Challenges – The ₹3,500 lakh investment in Shri Ahimsa Healthcare Private Limited’s new manufacturing unit may face delays, budget overruns, and regulatory dependencies, potentially impacting operations and financial stability.
- Audit Observations – Statutory Auditors have highlighted certain qualifications in audit reports for the half-year ending September 30, 2024, and fiscal years 2024, 2023, and 2022, which could raise concerns about financial compliance and transparency.
- Supply Chain & Vendor Risks – Delays in acquiring machinery, equipment, or completing construction work for the new unit could hinder expansion, increase costs, and affect overall operations.
Promoters
Mr Nemi Chand Jain
Mrs Sumitra Jain
Mr Amit Kumar Jain
Mr Sumit Jain
Mrs Prerna Jain
M/s Ahimsa Holdings Private Limited
M/s Bimneer Investments Private Limited.
Registrar & documents
Lead manager
Srujan Alpha Capital Advisors LLP
Registrar & contacts
Cameo Corporate Services Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
E-94, RIICO Industrial Area Bagru, Ext. Bagru
0141-2202482
[email protected]Company website ↗Frequently Asked Questions
What is Shri Ahimsa Naturals IPO GMP today?
As of today, Shri Ahimsa Naturals IPO Grey Market Premium (GMP) is reported at +₹19.5 per share. Based on the upper price band of ₹119, the estimated listing price is ₹138.5 (+16.4% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Shri Ahimsa Naturals IPO?
The minimum bid lot size for Shri Ahimsa Naturals IPO is 1,200 shares. At the cut-off price of ₹119 per share, retail investors need a minimum application amount of ₹1,42,800 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Shri Ahimsa Naturals IPO allotment status be announced?
The allotment status for Shri Ahimsa Naturals IPO is scheduled to be finalized on 28 Mar 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Cameo Corporate Services Limited's official portal or via BSE/NSE allotment portals.
How can I check Shri Ahimsa Naturals IPO allotment status online by PAN?
To check Shri Ahimsa Naturals IPO allotment status: 1) Visit the registrar portal (Cameo Corporate Services Limited) or the BSE IPO allotment page. 2) Select 'Shri Ahimsa Naturals Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.